These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 1314027)

  • 1. Nucleolar antigens and autoantibodies in hepatocellular carcinoma and other malignancies.
    Imai H; Ochs RL; Kiyosawa K; Furuta S; Nakamura RM; Tan EM
    Am J Pathol; 1992 Apr; 140(4):859-70. PubMed ID: 1314027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies in viral hepatitis-related hepatocellular carcinoma.
    Imai H; Kiyosawa K; Chan EK; Tan EM
    Intervirology; 1993; 35(1-4):73-85. PubMed ID: 8407252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing titers and changing specificities of antinuclear antibodies in patients with chronic liver disease who develop hepatocellular carcinoma.
    Imai H; Nakano Y; Kiyosawa K; Tan EM
    Cancer; 1993 Jan; 71(1):26-35. PubMed ID: 8380118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody detection using tumor-associated antigen mini-array in immunodiagnosing human hepatocellular carcinoma.
    Zhang JY; Megliorino R; Peng XX; Tan EM; Chen Y; Chan EK
    J Hepatol; 2007 Jan; 46(1):107-14. PubMed ID: 17067715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large scale identification of human hepatocellular carcinoma-associated antigens by autoantibodies.
    Wang Y; Han KJ; Pang XW; Vaughan HA; Qu W; Dong XY; Peng JR; Zhao HT; Rui JA; Leng XS; Cebon J; Burgess AW; Chen WF
    J Immunol; 2002 Jul; 169(2):1102-9. PubMed ID: 12097419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibody responses in Chinese hepatocellular carcinoma.
    Zhang JY; Wang X; Peng XX; Chan EK
    J Clin Immunol; 2002 Mar; 22(2):98-105. PubMed ID: 11998899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diversity of antinuclear antibody responses in hepatocellular carcinoma.
    Covini G; von Mühlen CA; Pacchetti S; Colombo M; Chan EK; Tan EM
    J Hepatol; 1997 Jun; 26(6):1255-65. PubMed ID: 9210612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of tumor-associated antigens in human hepatocellular carcinoma by autoantibodies.
    Chen X; Fu S; Chen F; Chen H; Chen Z
    Oncol Rep; 2008 Oct; 20(4):979-85. PubMed ID: 18813843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in nucleolar antigens of rat liver and Novikoff hepatoma ascites cells.
    Davis FM; Busch RK; Yeoman LC; Busch H
    Cancer Res; 1978 Jul; 38(7):1906-15. PubMed ID: 77722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic proteins of nucleolar chromatin of Novikoff hepatoma ascites cells.
    Busch RK; Busch H
    Tumori; 1977; 63(4):347-57. PubMed ID: 201061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Screening hepatocellular carcinoma autoantibodies by serological proteome analysis].
    Feng JT; Liu YK; Dai Z; Zhou HJ; Song HY; Qin LX; Jin H; Lu HJ; Tang ZY
    Zhonghua Gan Zang Bing Za Zhi; 2005 Nov; 13(11):832-5. PubMed ID: 16313728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of HCC-22-5 tumor-associated antigen and antibody response in patients.
    Zhou SF; Xie XX; Bin YH; Lan L; Chen F; Luo GR
    Clin Chim Acta; 2006 Apr; 366(1-2):274-80. PubMed ID: 16356486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of tumour antigens in sera of patients with hepatocellular carcinoma using monoclonal antibodies.
    Wong LY; Chan SH; Oon CJ
    Asian Pac J Allergy Immunol; 1990 Dec; 8(2):83-6. PubMed ID: 1965408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant increase in the antibody to Gal alpha 1-3Gal structure in sera of patients with hepatocellular carcinoma after transcatheter arterial embolization.
    Kashiwagi M; Ikeda Y; Iwamori M; Toda G; Nagai Y
    Cancer Res; 1989 Aug; 49(16):4396-401. PubMed ID: 2545342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleolar hypertrophy correlates with hepatocellular carcinoma development in cirrhosis due to HBV infection.
    Trerè D; Borzio M; Morabito A; Borzio F; Roncalli M; Derenzini M
    Hepatology; 2003 Jan; 37(1):72-8. PubMed ID: 12500191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies against glucose-regulated protein 78 as serological biomarkers in metastatic and recurrent hepatocellular carcinoma.
    Ying X; Han SX; He CC; Zhou CY; Dong YP; Cai MJ; Sui X; Ma CX; Sun X; Zhang YY; Gou WL; Mason C; Zhu Q
    Oncotarget; 2017 Apr; 8(15):24828-24839. PubMed ID: 28186997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of Ra1A and its tissue-specific expression in hepatocellular carcinoma.
    Wang K; Chen Y; Liu S; Qiu S; Gao S; Huang X; Zhang J; Peng X; Qiani W; Zhang JY
    Int J Immunopathol Pharmacol; 2009; 22(3):735-43. PubMed ID: 19822090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and partial characterization of a nucleolar antigen with a molecular weight of 145,000 found in a broad range of human cancers.
    Freeman JW; McRorie DK; Busch RK; Gyorkey F; Gyorkey P; Ross BE; Spohn WH; Busch H
    Cancer Res; 1986 Jul; 46(7):3593-8. PubMed ID: 3518918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing HEp-2 cell line with rat liver in routine screening test for antinuclear and antinucleolar autoantibodies in autoimmune diseases.
    Prost AC; Abuaf N; Rouquette-Gally AM; Homberg JC; Combrisson A
    Ann Biol Clin (Paris); 1987; 45(6):610-7. PubMed ID: 3326434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human autoantibodies against a nucleolar protein.
    Kindås-Mügge I
    Biochem Biophys Res Commun; 1989 Sep; 163(2):1119-27. PubMed ID: 2675830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.